Connect with us

Emerging Markets

XMET (Xxstream Entertainment) Powerful Reverse Merger (RM) SPAC Name Change to Shenzhen Houmu Wealth Management

Published

2 years ago

on

XMET has affected a 100 for 1 reverse stock split and changed its name to Houmu Holdings Ltd. Temporarily trading as XMETD this is probably a good thing for the Company and shareholders over the long term. There is a common misconception on the bulletin boards that RS means a falling stock price and this is not true at all. Looking back over the past few years many high-profile penny stocks that saw RS actually made significant runs right after the RS. We wrote about some otc that did RS and made big moves direclty after the RS a few years ago so its a bit out of date: “CTSO did a 25 for 1 RS the stock opened after the RS at just over $4 a share and quickly ran to over $12 in 3 weeks. SIAF did a 9.9 for 1 RS and the stock opened after the RS at just over $6 a share and was trading over $9 by the next day. Even if we look back farther and take MSLP which did a 850 for 1 RS and opened after the RS at just over $4 and was trading over $12 a share within 6 months. So I reject the general consensus that is going around that RS will result in a dropping PPS; on the contrary RS could be the catalyst that takes this one to the next level. We will update as more details emerge. To keep updated enter your email below.

XMET (Xxstream Entertainment) is heating up and is once again in full beast mode as the stock saw a massive reversal off $0.005 last week. This comes as a welcome change after many days of choppy waters due in part to a significant short attack that is now behind it. On Friday there was a real change in the wind as large buyers showed up and heavy accumulation in XMET began again in earnest speaking volumes of what is to come this week. Any official news on XMET could send this one into a whole new dimension as investors look forward to the coming name change to Houmu Holdings Shenzhen Atsumu Wealth Management Co., Ltd., abbreviated as Atsumu Fortune, was established in March 2015 and is headquartered in Jinan Hanyu Jingu, the regional financial center of Shandong Province, with a registered capital of 100 million yuan ($15 million USD) Houmo Holdings is focused on comprehensive asset allocation consulting, investment product screening, Corporate financing services for domestic high-net-worth individuals and institutions, asset management and other diversified financial services. 

Big things are happening with XMET ever since HK Morgan Stanley broker Wei Tian purchased the SPAC for $220,000 from David Lazar. According to court records there was a status check completed on Friday. Also, the Custodianship with David Lazar will be officially terminated on March 19.  XMET origins as a David Lazar, OTC SPAC’s/CUSTODIAN Plays is significant as many of these plays have been hugely successful making powerful sustained runs indicative of a clean share structure. David Lazar custodianship/SPAC RM deals have been so successful in fact they have even spawned the message board; David Lazar, OTC SPAC’s/CUSTODIAN Plays on Investorshub.com. It is also important to note that new CEO Wei Tian is a season executive who has participated in many successful IPOs. He also participated and issued the Deutsche Bank Subprime Mortgage Bonds Derivatives Plan, participate and issued the HSBC trust asset-backed securitization Plan.  XMET has huge interest from investors who are looking for a move back over $0.02 and a serious powerhouse blue sky breakout. This coming reverse merger with Houmu Holdings could be the catalyst that propels XMET into a whole new dimension. 

Xxstream Entertainment (OTCMKTS: XMET) is a clean shell that was dormant for many years but has come to life as the Company recently filed its quarterly report becoming Pink Current on OtcMarkets.  XXStream, Inc. was formed on May 21, 2005, with an initial business plan to offer a new type of entertainment portal on the web that is built from the ground up for today’s always on high bandwidth 18-35 year old demographic. The club was intended to be the first portal online that would blend online and offline entertainment in ways that leverage the synergies of the real and virtual worlds in unique ways. The Company intended to create a new media company that would provide multi-cultural digital content for consumers in every major market segment in Europe, South America, Asia, and Mexico. Club XXStream was targeting a young global demographic, with the primary focus being 18-35 years of age, as this demographic group is affluent, technically sophisticated, and is always seeking new ways to find entertainment off and online. Club XXStream was in partnership discussions large media content and technology providers including MTV, Microsoft, Macromedia, Real Networks, Yahoo, AOL/Time Warner 

XMET was created in 2006 as a dividend to trap the NS on PYCT, it never had a biz, no debt, never traded, it was grey sheet, until David Lazar got it uplisted to the OTC pink venue, and as of July 17th 2020 he was granted custodianship (see link atached) Mario Pino former CEO has died recently, and clearly has no connection or influence on XMET. 

On July 20, 2020, Custodian Ventures, LLC was appointed as the custodian of the Company by the Eighth Judicial Court of Nevada pursuant to Case No. A-20-816267-B. David Lazar is a private investor and since February of 2018, Mr. Lazar has been the managing member of Custodian Ventures LLC, where he specializes in assisting distressed public companies. Since March 2018, David has acted as the managing member of Activist Investing LLC, which specializes in active investing in distressed public companies. David has a diverse knowledge of financial, legal and operations management; public company management, accounting, audit preparation, due diligence reviews, and SEC regulations.  

There is a great article on OTC SPAC’s/CUSTODIAN Plays here.

Image result for David Lazar, OTC SPAC’s/CUSTODIAN Plays

In recent years there have been a number of hugely successful David Lazar custodianship/SPAC RM deals that have even spawned the message board; David Lazar, OTC SPAC’s/CUSTODIAN Plays on Investorshub.com.  

Investor Sentiment in XMET is high. On Decmeber 1 the same day Microcapdaily first covered XMET Clay Trader posted a technical analysis on XMET on youtube.

To get an inside look at XMET Subscribe to Microcapdaily.com immediately by entering your Email below

Microcapdaily reported on XMET on December 1, 2020 just as XMET was rising up out of the triple zeroes Microcapdaily reported its article: Custodianship/SPAC; the Rise of Xxstream Entertainment (OTCMKTS: XMET) Stating: “Xxstream Entertainment (OTCMKTS: XMET) is another exciting RM play getting noticed by penny stock speculators and trading big volume topping $4 million + per day in dollar volume. XMET is another custodianship/SPAC from David Lazar. Reverse Merger stocks are proving to be more explosive than biotech and XMET has all the markings of a coming Reverse Merger. After many years of dormancy XMET has come to life filing its quarterly report becoming Pink Current on OtcMarkets. On July 20, 2020, Custodian Ventures, LLC was appointed as the custodian of the Company by the Eighth Judicial Court of Nevada pursuant to Case No. A-20-816267-B. David Lazar is a private investor and since February of 2018, Mr. Lazar has been the managing member of Custodian Ventures LLC, where he specializes in assisting distressed public companies. Since March 2018, David has acted as the managing member of Activist Investing LLC, which specializes in active investing in distressed public companies. David has a diverse knowledge of financial, legal and operations management; public company management, accounting, audit preparation, due diligence reviews, and SEC regulations. In recent years there have been a number of hugely successful David Lazar custodianship/SPAC RM deals that have even spawned the message board; David Lazar, OTC SPAC’s/CUSTODIAN Plays on Investorshub.com.  

Image result for XXSTREAM ENTERTAINMENT, INCOn December 14 XMET filed an 8k: Item 5.01 Changes in Control of Registrant. On December 9, 2020, as a result of a private transactions, 100,000,000 shares of Series A Preferred Stock, $0.001 par value per share of XXStream Entertainment, Inc., a Nevada corporation were transferred from Custodian Ventures, LLC to Wei Tian. As a result, the Purchaser became an approximately 93% holder of the voting rights of the issued and outstanding share capital of the Company on a fully-diluted basis of the Company, and became the controlling shareholder. The consideration paid for the Shares was $220,000. The source of the cash consideration for the Shares was personal funds of the Purchaser. In connection with the transaction, David Lazar released the Company from all debts owed to him. Other than as described below, there are no arrangements or understandings among both the former and new control persons and their associates with respect to the election of directors of the Company or other matters. The information set forth in Item 5.02 of this Form 8-K is incorporated by reference into this Item 5.01. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 9, 2020, the existing director and officer resigned immediately. Accordingly, David Lazar, serving as a director and an officer, ceased to be the Company’s Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and a Director. At the effective date of the transfer, Wei Tian consented to act as the new President, CEO, CFO, Treasurer, Secretary and Chairman of the Board of Directors of the Company.  

Wei Tian has a Bachelor Degree in Finance at Capital University of Economics and Business, and a Bachelor Degree in International Economy and Trade at Shandong University. Wei Tian is a certified Futures Advisor, Securities Analyst, and Market Risk Analyst. We Tian worked at Morgan Stanley, in the Department of Global Capital Markets in HK, at China Futures Co., Ltd., in the Department of Research, and at China Securities Co., Ltd., in the Department of Investment Banking/Research. Wei Tian participated and issued the Deutsche Bank Subprime Mortgage Bonds Derivatives Plan, participate and issued the HSBC trust asset-backed securitization Plan, and participated in multiple IPOs. Wei Tian has been appointed as a Chief Executive Officer, President, Secretary, Treasurer and Chairman of Board of Directors of the Company.  

RM PLAY XMET NEW CO IS: SHENZHEN HOUMU WEALTH MANAGEMENT CO., LTD.

For More on XMET Subscribe Right Now!

XMET (Xxstream Entertainment) is heating up and is once again in full beast mode as the stock saw a massive reversal off $0.005 last week. This comes as a welcome change after many days of choppy waters due in part to a significant short attack that is now behind it. On Friday there was a real change in the wind as large buyers showed up and heavy accumulation in XMET began again in earnest speaking volumes of what is to come this week. Any official news on XMET could send this one into a whole new dimension as investors weigh the coming name change to Houmu Holdings with its corporate website located at: houmucf.com Shenzhen Atsumu Wealth Management Co., Ltd., abbreviated as Atsumu Fortune, was established in March 2015 and is headquartered in Jinan Hanyu Jingu, the regional financial center of Shandong Province, with a registered capital of 100 million yuan ($15 million USD) Houmo Holdings is focused on comprehensive asset allocation consulting, investment product screening, Corporate financing services for domestic high-net-worth individuals and institutions, asset management and other diversified financial services. Big things are happening with XMET ever since HK Morgan Stanley broker Wei Tian purchased the SPAC for $220,000 from David Lazar. According to court records there was a status check completed on Friday. Also, the Custodianship with David Lazar will be officially terminated on March 19.  XMET origins as a David Lazar, OTC SPAC’s/CUSTODIAN Plays is significant as many of these plays have been hugely successful making powerful sustained runs indicative of a clean share structure. David Lazar custodianship/SPAC RM deals have been so successful in fact they have even spawned the message board; David Lazar, OTC SPAC’s/CUSTODIAN Plays on Investorshub.com. It is also important to note that new CEO Wei Tian is a season executive who has participated in many successful IPOs. He also participated and issued the Deutsche Bank Subprime Mortgage Bonds Derivatives Plan, participate and issued the HSBC trust asset-backed securitization Plan.  XMET has huge interest from investors who are looking for a move back over $0.02 and a serious powerhouse blue sky breakout. This coming reverse merger with Houmu Holdings could be the catalyst that propels XMET into a whole new dimension.  We will be updating on XMET when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with XMET.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in XMET either long or short and we have not been compensated for this article.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Emerging Markets

Strong Financials and Social Media Buzz Propel Forza X1, Inc. (NASDAQ:FRZA) to New Heights

Published

2 days ago

on

June 6, 2023

By

Forza X1, Inc. (Nasdaq: FRZA) shares witnessed an exceptional and unforeseen surge in its share price, skyrocketing by 151% early morning of June 5th, 2023.

Forza X1, Inc. (Nasdaq: FRZA) shares witnessed an exceptional and unforeseen surge in its share price, skyrocketing by 151% early morning of June 5th, 2023. This surge was accompanied by an unprecedented level of trading volume, marking a significant departure from the previously observed average. Notably, the stock’s trading volume had been relatively low in recent months, with numerous days experiencing trading activity of less than 1,000 shares. Without any apparent news or filings, the cause behind this sudden surge remains a subject of intrigue and speculation among market participants.

What happened?

Firstly it’s important to note that $FRZA is a spin-off of Twin Vee PowerCats Co. (Nasdaq: VEEE). $VEEE is the parent company handling the design, manufacturing, and distribution of recreational and commercial, off-shore power catamaran boats while $FRZA is the new developer of electric sport boats with a mission to accelerate the adoption of sustainable recreational boating.

To Discover the Inside Scoop on FRZA, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Upon examination of the company, no discernible filings or press releases have been identified to account for today’s remarkable shift. However, it seems that a tweet disseminated by the company caught the attention of retail investors, subsequently generating an enormous surge in trading volume.

This recent occurrence serves as yet another compelling demonstration of the significant impact that the retail community can exert when armed with information regarding a small float micro-cap stock, particularly when the conditions align favorably and validate the potential for substantial gains. The tweet, skillfully crafted by the company’s social media team, featured a compelling GIF and clever “Don’t miss the boat” blurb, demonstrating a keen understanding of their business’s essence. 

The timely and engaging content proved to be a perfect execution, capturing the attention and imagination of investors in a manner that resonated deeply with the nature of the company’s operations.

Overview of Twin Vee PowerCats Co. Financials

Could the surge in share price also reflect the market’s enthusiastic response to Twin Vee’s strong financial results for the first quarter of 2023? 

On May 15, 2023, Twin Vee PowerCats Co. released its financials demonstrating a substantial increase in net revenue and notable improvements in the gas-powered boat segment.

https://twitter.com/JohnZidar/status/1665685698400141313?s=20

Twin Vee PowerCats Co. (Nasdaq: VEEE) reported strong financial results for the first quarter ended March 31, 2023. The company experienced a notable 51% increase in net revenue, reaching $8.9 million compared to $5.9 million in the same period last year. The gas-powered boat segment achieved a net income of $181,000, significantly improving from the net loss of $626,000 in Q1 2022.

However, as per GAAP accounting policy, Twin Vee’s consolidated financial statements resulted in a total net loss of $1.8 million for the quarter, primarily due to their majority ownership in Forza X1, Inc. (Nasdaq: FRZA), an electric boat company. Twin Vee reported cash, cash equivalents, restricted cash, and marketable securities of approximately $12.6 million as of March 31, 2023.

The company has been expanding its product lineup, including introducing the Aquasport mono-hull boat brand. Twin Vee is confident these efforts will contribute to business scalability and brand growth. They aim to optimize inventory levels and production costs while closely monitoring market conditions, dealer inventories, and economic indicators.

Financial highlights for Q1 2023

  • Total revenue: $8,877,000 (51% increase compared to Q1 2022)
  • Gross profit: $3,222,000
  • Net income from gas-powered boats segment: $182,000
  • Net loss from Forza X1 (electric boat entity): $2,005,000
  • Loss from Fix My Boat (franchise business): $5,000
  • Adjusted net loss (excluding non-cash charges): $1,347,000
  • Adjusted net income from gas-powered boats segment: $265,000

Twin Vee’s consolidated cash, cash equivalents, restricted cash, and marketable securities were $23,457,000 as of March 31, 2023. Forza X1 reported $10,683,000 in the same category, while Twin Vee’s core business had $12,643,000, and Fix My Boat had approximately $132,000.

We will closely monitor the performance of Forza X1, Inc. (Nasdaq: FRZA) in the coming weeks, considering that it is a spinoff from its parent company. It is crucial to conduct thorough research, particularly for companies like FRZA that have yet to achieve profitability. However, it is worth noting that the parent company has been making notable progress, as evidenced by its recent financial results, which revealed a substantial increase in the bottom line.

We will update you on FRZA when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Sasin Tipchai from Pixabay

Continue Reading

Emerging Markets

Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership

Published

1 week ago

on

May 31, 2023

By

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic.

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.

“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”

More on Nociscan Technology

Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.

What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers. 

To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.

https://twitter.com/TigerLineTrades/status/1663527784143093762?s=20

Nociscan Study

They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.

Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”

It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.

Conclusion

The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.

We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by PIRO from Pixabay

Continue Reading

Emerging Markets

Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval

Published

3 weeks ago

on

May 21, 2023

By

Aemetis (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the EPA.

Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.

Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.

They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.

They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.

To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.

The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.

Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.

https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20

Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?

The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.

The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.

The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies. 

The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.

We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leopold Böttcher from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.